On Sunday February 21, 2016 in Boston, the AIDS Treatment Activists Coalition, AVAC, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research. The workshop has become an annual event that takes place immediately prior to the Conference on Retroviruses and Opportunistic Infections (CROI). Presentations are posted below.

Presentations

• ACTIVATE: The tribulations of a panobinostat/interferon-alpha cure trial
  Daniel Kuritzkes, M.D., Chief of the Division of Infectious Diseases at Brigham & Women’s Hospital and Professor, Harvard Medical School
• Community perspective on the dialogue with the U.S. Food & Drug Administration (FDA) regarding the panobinostat plus alpha-interferon combination trial
  Lynda Dee, AIDS Action Baltimore
• Broadly neutralizing antibodies for HIV eradication
  Kathryn Stephenson, M.D., Assistant Professor of Medicine, Harvard Medical School
• Early HIV-specific CD8+ T cell responses in treated and untreated hyper acute HIV infection in the FRESH (Females Rising through Education, Support, and Health) cohort in Umlazi Township, South Africa
  Zaza Ndhlovu Ph.D., Instructor, Ragon Institute of MGH, MIT & Harvard and Faculty, HIV Pathogenesis Program, Nelson Mandela School of Medicine, University of KwaZulu Natal, South Africa
• Report-back from EATG HIV cure research meeting in Barcelona, October 20th, 2015
  Giulio Maria Corbelli, EATG
• The NIH’s Recombinant DNA Advisory Committee (RAC) and its role in HIV cure research
  Lynda Dee, AIDS Action Baltimore
• International AIDS Society Towards an HIV Cure: Community Engagement Activities in 2016
  Slides kindly provided by Rosanne Lamplough and Anna Laura Ross, International AIDS Society Towards an HIV Cure Initiative
• Expanding Research Education: the Example of the START Clinical Trial Videos
  Moses Supercharger, INSIGHT Network Community Advisory Board